On this page

Attenuvax

Measles Virus Vaccine Live

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Attenuvax
Proper name
Measles Virus Vaccine Live
Licence type
351(a)
BLA number
101068
Applicant
Merck Sharp & Dohme LLC
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
NLT1000U/.5ML For Injection Subcutaneous Vial Disc March 21, 1963

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity